Mazindol: a new anorectic drug
Siani, V.
La Clinica Terapeutica 84(1): 100-101
1978
ISSN/ISBN: 0009-9074 PMID: 630811 Document Number: 134479
Document emailed within 1 workday
Related Documents
Mattei, R.; Carlini, E.A. 1995: Mazindol: anorectic and behavioral effects in female rats Archives Internationales de Pharmacodynamie et de Therapie 330(3): 279-287Delitala, G.; Alagna, S.; Masala, A. 1977: Mazindol (AN-448): a new non-amphetamine anorectic in the treatment of exogenous obesity La Clinica Terapeutica 81(6): 547-554
Komorowski, J.M.; Zwaigzne-Raczyńska, J.; Owczarczyk, I.; Gołebiowska, M.; Zarzycki, J. 1982: Effect of mazindol (teronac) on various hormonal indicators in children with simple obesity Pediatria Polska 57(4): 241-246
Rath, R.; Vondra, K.; Bass, A.; Kujalova, V.; Wenkeova, J. 1979: The effect of mazindol on metabolic and regulatory changes in obese women during weight reduction International Journal of Obesity 3(2): 133-140
Xu, C.; Reith, M.E. 1997: WIN 35,428 and mazindol are mutually exclusive in binding to the cloned human dopamine transporter Journal of Pharmacology and Experimental Therapeutics 282(2): 920-927
Inoue, S.; Egawa, M.; Satoh, S. 1984: Effects of an anorexiant, mazindol, on metabolic abnormalities of rats with ventromedial hypothalamic lesions Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 83(5): 441-449
Gogerty, J.H.; Penberthy, C.; Iorio, L.C.; Trapold, J.H. 1975: Pharmacological analysis of a new anorexic substance: 5-hydroxy-5(4'-chlorophenyl)-2, 3-dihydro-5H-imidazo-(2, 1-a) isoindole (Mazindol) Archives Internationales de Pharmacodynamie et de Therapie 214(2): 285-307
Felt, V. 1976: Treatment of obesity using a new anorectic Vnitrni Lekarstvi 22(4): 371-374
Kawano-Takahashi, Y.; Ohminaji, H.; Ubagai, E.; Okuda, H. 1984: Mechanisms of action of mazindol in preventing onset and development of obesity induced by gold thioglucose injection International Journal of Obesity 8(6): 655-664
Mashford, M.L. 1984: Anorectic drugs. a cause of pulmonary hypertension? Medical Journal of Australia 140(10): 597
Thomas, S.H. 1998: Serious adverse reactions to anorectic agents Adverse Drug Reactions and Toxicological Reviews 17(4): 209-225
Thomas, S.H. 1998: Serious adverse reactions to anorectic agents Adverse Drug Reactions and Toxicological Reviews 17(4): 209-225
Fujimoto, K.; Sakata, T.; Arase, K.; Tsutsui, K.; Fukushima, M. 1984: Changes in meal patterns and endogenous chemical determinants related to food intake following intra-ventricle III infusion of mazindol Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 83(5): 425-432
Desnuelle, C.; Serratrice, G.; N'guyen, V.K.; Richelme, C.; Pinsard, N. 1989: A therapeutic trial of mazindol versus placebo in Duchenne muscular dystrophy. a one-year follow-up study of 14 children Archives Francaises de Pediatrie 46(10): 759-765
Jori, A.; Dolfini, E. 1977: Biochemical interaction between anorectic drugs and piribedil Journal of Pharmacy and Pharmacology 29(9): 581-582
Bruera, E.; Carraro, S.; Roca, E.; Barugel, M.; Chacon, R. 1986: Double-blind evaluation of the effects of mazindol on pain, depression, anxiety, appetite, and activity in terminal cancer patients Cancer Treatment Reports 70(2): 295-298
Girdhar, A.; Sharma, D.C.; Sachdev, K.S. 1982: Anorectic effect of SK and F 38393, a new dopamine agonist in rats Indian Journal of Physiology and Pharmacology 26(4): 317-320
Jacquot, S.; Lamy, P.; Cohen, J.P.; Le Quintrec, Y. 1989: Gastric necrosis after a bulimia episode in an anorectic patient Presse Medicale 18(39): 1932
Abdallah, A.H. 1971: On the role of norepinephrine in the anorectic effect of D-amphetamine in mice Archives Internationales de Pharmacodynamie et de Therapie 192(1): 72-77
Curtis-Prior, P.B.; Oblin, A.R.; Tan, S. 1980: Anti-hypertriglyceridaemic activity of some phenylethylamine anorectic compounds International Journal of Obesity 4(2): 111-119